Vargas-Quevedo Ericka, Ordoñez-Gutiérrez Eduardo, Trejo-Gómora Jorge Enrique, Chávez-Aguilar Lénica Anahí, Peña-Vélez Rubén
Servicio de Medicina Interna Pediátrica, Centro Médico Nacional 20 de Noviembre, Ciudad de México, México.
Servicio de Banco de Sangre, Centro Médico Nacional 20 de Noviembre, Ciudad de México, México.
Rev Chil Pediatr. 2018 Apr;89(2):236-240. doi: 10.4067/S0370-41062018000200236. Epub 2018 Apr 4.
The antiphospholipid syndrome is an acquired autoimmune thrombophilia, characterized by arterial and/or venous thrombosis. Rarely, this condition can have a catastrophic presenta tion, with high mortality, and presence of microangiopathy and involvement of three or more organs.
To describe the clinical presentation and evolution of a pediatric patient with catastrophic antiphospholipid syndrome, with a seronegative onset form, whose response to aggressive therapy was favorable.
Adolescent female, with a one-week history of pain, increased abdo minal volume and edema in the lower extremities. Generalized lupus erythematosus was diagnosed and the neoplastic process was ruled out. During its evolution, she presented various thrombotic events, initially with the presence of negative antiphospholipid antibodies, which were subsequently positive. The patient presented multisystemic failure secondary to multiorgan thrombosis, required hemodynamic and ventilatory support. It was managed with low molecular weight heparin, plas mapheresis, anticoagulation, immunosuppression and boluses of rituximab with excellent response.
We consider this case interesting because it is an infrequent diagnosis in the pediatric age and whose suspicion, timely and aggressive intensive management, can change the poor progno sis and high mortality of these patients.
抗磷脂综合征是一种获得性自身免疫性血栓形成倾向疾病,其特征为动脉和/或静脉血栓形成。这种情况很少会出现灾难性表现,死亡率高,伴有微血管病且累及三个或更多器官。
描述一名患有灾难性抗磷脂综合征的儿科患者的临床表现及病情发展,该患者为血清阴性起病形式,对积极治疗反应良好。
青春期女性,有一周的疼痛、腹部体积增大及下肢水肿病史。诊断为系统性红斑狼疮,排除肿瘤性疾病。在病程中,她出现了各种血栓形成事件,最初抗磷脂抗体阴性,随后转为阳性。患者因多器官血栓形成继发多系统功能衰竭,需要血流动力学和通气支持。采用低分子量肝素、血浆置换、抗凝、免疫抑制及利妥昔单抗冲击治疗,反应良好。
我们认为该病例很有趣,因为在儿科年龄组中这种诊断并不常见,且及时、积极的强化管理可改变这些患者的不良预后和高死亡率。